How many institutional investors hold KRYS?

2 tracked institutional investors disclosed a position in KRYS (KRYSTAL BIOTECH INC) in their most recent 13F filing.

Who is the largest institutional holder of KRYS?

Izzy Englander, Millennium Management, holds the largest disclosed position in KRYS, valued at $26M.

Where does this KRYS ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

KRYS — KRYSTAL BIOTECH INC

Name: KRYSTAL BIOTECH INC (KRYS) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying KRYS?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net accumulation · 1 buying vs 0 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their KRYS position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime).

Supporting evidence

+1 tracked investor added or increased positions last quarter (Ray Dalio)
+2 tracked investors reported holding KRYS at their latest filing
+Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource

Contradicting evidence — always shown

−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About KRYSTAL BIOTECH INC (KRYS)

KRYSTAL BIOTECH INC (KRYS) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $26M. Across recent filings, tracked investors recorded 3 new positions, 3 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in KRYS

/100

Strong Institutional Accumulation

Added / Increased6

Reduced0

Exited1

BearishBullish

Crowded Trade Score™

How many top investors track KRYS

/100

Undiscovered

2investors

Only 2 tracked investors report this position.

UndiscoveredCrowded

151015+

KRYS Ownership Composition

How KRYSTAL BIOTECH INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Macro

56% of tracked value

Institutions

tracked investors

Total Reported

$36.2M

combined 13F value

Macro55.9%
Multi-Strategy / Quant44.1%

Macro(1)

55.9%

Multi-Strategy / Quant(1)

44.1%

Tracked investors currently reporting KRYS

2 tracked investors have since exited this position — listed separately below.

Investor	Firm	Shares	Market value	% of portfolio	As of
Ray Dalio	Bridgewater Associates	54.5K	$20.3M	0.08%	Jun 30, 2026
Ken Griffin	Citadel Advisors	43K	$16M	0.00%	Jun 30, 2026

Ray DalioJun 30, 2026
Bridgewater Associates
Shares
54.5K
Value
$20.3M
% Portfolio
0.08%
Ken GriffinJun 30, 2026
Citadel Advisors
Shares
43K
Value
$16M
% Portfolio
0.00%

Previously held KRYS

These investors reported KRYS in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

Investor	Firm	Last reported shares	Value then	Last held
Izzy Englander	Millennium Management	4.1K	$1.1M	Mar 31, 2026
Paul Tudor Jones	Tudor Investment Corp	14.5K	$3.7M	Mar 31, 2026

Recent activity

Investor	Action	Δ %	Current value	Filing date
Ken Griffin	New	—	$10.2M	Aug 14, 2025
Ken Griffin	Sold	-100.00%	$0	Nov 14, 2025
Ken Griffin	New	—	$100.9K	Feb 17, 2026
Ray Dalio	New	—	$1.7K	Nov 13, 2025
Ray Dalio	Increased	3.00%	$2.5K	Feb 13, 2026
Ray Dalio	Increased	362.98%	$12M	May 15, 2026
Ray Dalio	Increased	17.52%	$20.3M	Aug 14, 2026

Ken Griffin
New
$10.2MAug 14, 2025
Ken Griffin
Sold
$0(-100.00%)Nov 14, 2025
Ken Griffin
New
$100.9KFeb 17, 2026
Ray Dalio
New
$1.7KNov 13, 2025
Ray Dalio
Increased
$2.5K(3.00%)Feb 13, 2026
Ray Dalio
Increased
$12M(362.98%)May 15, 2026
Ray Dalio
Increased
$20.3M(17.52%)Aug 14, 2026

Frequently asked questions

How many institutional investors hold KRYS?: 2 tracked institutional investors disclosed a position in KRYS (KRYSTAL BIOTECH INC) in their most recent 13F filing.
Who is the largest institutional holder of KRYS?: Izzy Englander, Millennium Management, holds the largest disclosed position in KRYS, valued at $26M.
Did institutional ownership of KRYS increase or decrease?: Across recent 13F filings, tracked investors recorded 3 new positions, 3 increased, 0 reduced, and 1 fully exited KRYS.
Where does this KRYS ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.